Royal Prima PT (PRIM) - Total Liabilities
Based on the latest financial reports, Royal Prima PT (PRIM) has total liabilities worth Rp111.14 Billion IDR (≈ $6.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Royal Prima PT - Total Liabilities Trend (2014–2024)
This chart illustrates how Royal Prima PT's total liabilities have evolved over time, based on quarterly financial data. See Royal Prima PT (PRIM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Royal Prima PT Competitors by Total Liabilities
The table below lists competitors of Royal Prima PT ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kritika Wires Limited
NSE:KRITIKA
|
India | Rs728.73 Million |
|
ZOONO Group Ltd
AU:ZNO
|
Australia | AU$2.53 Million |
|
KM Corporation
KQ:083550
|
Korea | ₩49.04 Billion |
|
Primega Group Holdings Limited Ordinary Shares
NASDAQ:PGHL
|
USA | $9.08 Million |
|
Frtek Co.Ltd
KQ:073540
|
Korea | ₩10.01 Billion |
|
Farmaceutica R
RO:RMAH
|
Romania | RON303.69 Million |
|
Defence Therapeutics Inc.
F:DTC
|
Germany | €2.59 Million |
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
USA | $3.35 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Royal Prima PT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PRIM market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.05 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Royal Prima PT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Royal Prima PT (2014–2024)
The table below shows the annual total liabilities of Royal Prima PT from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp122.17 Billion ≈ $7.16 Million |
+145.89% |
| 2023-12-31 | Rp49.69 Billion ≈ $2.91 Million |
-4.20% |
| 2022-12-31 | Rp51.86 Billion ≈ $3.04 Million |
-68.97% |
| 2021-12-31 | Rp167.11 Billion ≈ $9.79 Million |
+174.17% |
| 2020-12-31 | Rp60.95 Billion ≈ $3.57 Million |
+0.95% |
| 2019-12-31 | Rp60.38 Billion ≈ $3.54 Million |
-4.81% |
| 2018-12-31 | Rp63.43 Billion ≈ $3.72 Million |
+7.11% |
| 2017-12-31 | Rp59.22 Billion ≈ $3.47 Million |
+126.60% |
| 2016-12-31 | Rp26.13 Billion ≈ $1.53 Million |
-0.95% |
| 2015-12-31 | Rp26.38 Billion ≈ $1.55 Million |
+89.58% |
| 2014-12-31 | Rp13.92 Billion ≈ $815.50K |
-- |
About Royal Prima PT
PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more